NT-proBNP is an easily accessible and cost-effective biomarker that can be measured at the time of a PE diagnosis to enhance prognosis, prevent complications, and lower risks in both the acute and long-term phases in patients with PE and neoplasms [31,32]. Here, NPPB is linked to neoplasm.